Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for prevention of headache and hypotension after spinal anesthesia
IRCT20211218053439N1Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in post-dural puncture headache (PDPH) and hypotension comparing Cyproheptadine with Placebo (2 arms). Primary endpoints: Headache and Hypotension. Started Feb 2022; status: completed.
02
Drugs
cyproheptadine
03
Conditions
post-dural puncture headache (PDPH)hypotension
Beyond the preview
Go deeper on IRCT20211218053439N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211218053439N1.